Related Experiment Video
Updated: Jan 27, 2026
09:39
Assessing Specificity of Anticancer Drugs In Vitro
Published on: March 23, 2016
9.8K
Estimation of Kidney Function in Oncology: Implications for Anticancer Drug Selection and Dosing
Morgan A Casal1, Thomas D Nolin1,2, Jan H Beumer3,4,5
1Departments of Pharmacy and Therapeutics and.
Summary
Accurate kidney function estimation is crucial for cancer patients. Using the more precise CKD-EPI equation, rather than Cockcroft-Gault, improves drug dosing and clinical trial eligibility.
Area of Science:
- Nephrology
- Oncology
- Pharmacology
Background:
- Accurate estimation of kidney function is vital in oncology for drug dosing, agent selection, and clinical trial eligibility.
- Inaccurate estimations can lead to toxicity (overdosing) or therapeutic failure (underdosing).
- The Cockcroft-Gault formula is widely used but less accurate than the CKD-EPI equation.
Purpose of the Study:
- To review contemporary methods for estimating kidney function in cancer patients.
- To discuss the clinical implications of different estimation methods on drug dosing and trial eligibility.
- To highlight the need for updated guidelines based on more accurate kidney function estimates.
Main Methods:
- Review of current literature on kidney function estimation in cancer patients.
- Analysis of the accuracy of Cockcroft-Gault and CKD-EPI equations.
- Case study analysis using carboplatin and cisplatin dosing and eligibility.
Main Results:
- The CKD-EPI equation offers a more precise estimation of kidney function compared to Cockcroft-Gault.
- Traditional dosing and eligibility cutoffs, often based on Cockcroft-Gault, may not align with CKD-EPI estimates.
- Discrepancies can significantly impact treatment decisions and outcomes.
Conclusions:
- Contemporary kidney function estimation methods, particularly CKD-EPI, should be considered for cancer patient management.
- Re-evaluation of established dosing and eligibility criteria is necessary to incorporate more accurate kidney function estimates.
- Optimizing kidney function assessment can improve therapeutic efficacy and reduce toxicity in cancer care.
Related Concept Videos
01:25Dose-Response Relationship: Selectivity and Specificity
9.6K
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
9.6K
01:29Drug Dosing: Infants and Children
277
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
277
01:15Drug Dosing: Geriatric Patients
229
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
229
01:28Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
204
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
204
01:21Drug Dosing: Obese Patients
242
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
242
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
216
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
216